Delivery Order SPE2DB22D3016-SPE2DB24FBGB8
Award Date
9/5/24
Potential Completion Date
9/26/24
Potential Value
$9.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order with a Firm Fixed Price type valued at $1,684.36. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract has a completion date of June 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,656.80 firm fixed price contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract has a completion date of May 8, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract has a ceiling value of $1,656.80 and an ultimate completion date of September 3, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract has a ceiling value of $1,263.27 and is a Firm Fixed Price contract type. It is not a set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This federal contract award, identified as SPE2DB20D1100|SPE2DB24FD3X5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is a delivery order with a firm fixed price of $2,485.20 and a completion date of September 12, 2024. The award is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corporation,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The delivery order has a ceiling value of $3,313.60 and is a Firm Fixed Price contract. The ultimate completion date is August 28, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is being tasked with delivering this critical medication...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $70,093.32 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, awarded on August 5, 2024, has an ultimate completion date of August 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
The U.S. government awarded a $1,440.39 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, which has no set-aside designation, is for the provision of pharmaceutical and medical products to support the Defense Logistics Agency (DLA) Troop Support Medical. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
The U.S. Department of Defense (DoD) agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,137.49 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. This order falls under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD...
The U.S. government agency the Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $36,717.12 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed price and is set to run through June 6, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company...